Use of Tenckhoff catheter for peritoneal dialysis in terminal renal failure.
Over a period of 33 months a total of 2,146 peritoneal dialyses were carried out by means of indwelling Tenckhoff catheters in 65 patients suffering from terminal renal failure. The patients were maintained on peritoneal dialysis for periods varying from two weeks to 13 months. Treatment over long periods was possible in only a few cases. Infection and clotting, which tended to limit the functional life of the catheters, was reduced by rigid asepsis and by adding heparin to the dialysate. The Tenckhoff catheter was found to be valuable for peritoneal dialysis as a short-term measure, especially in patients in whom haemodialysis was not immediately feasible, in borderline cases when kidney function was not too seriously impaired, and as an alternative to haemodialysis when that was interrupted by complications.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001777:Blood Coagulation; D002404:Catheterization; D004926:Escherichia coli / Q000302:isolation & purification; D006493:Heparin; D006801:Humans; D017053:Infection Control; D007676:Kidney Failure, Chronic / Q000628:therapy; D016030:Kidney Transplantation; D008722:Methods; D010530:Peritoneal Dialysis; D010538:Peritonitis / Q000150:complications; D006435:Renal Dialysis; D013210:Staphylococcus / Q000302:isolation & purification; D000267:Tissue Adhesions; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D006493:Heparin